Anson Funds Management LP Sellas Life Sciences Group, Inc. Transaction History
Anson Funds Management LP
- $839 Million
- Q3 2024
A detailed history of Anson Funds Management LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 793,835 shares of SLS stock, worth $706,513. This represents 0.12% of its overall portfolio holdings.
Number of Shares
793,835
Previous 793,835
-0.0%
Holding current value
$706,513
Previous $992,000
-0.0%
% of portfolio
0.12%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding SLS
# of Institutions
39Shares Held
5.69MCall Options Held
1.67MPut Options Held
74.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.04 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA605KShares$538,6190.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$383,0270.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$274,5343.71% of portfolio
-
Opus Capital Group, LLC226KShares$201,2290.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $18.3M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...